UY37486A - FORMULACIONES LIPOSOMALES DE COMPUESTOS DE ß-LACTAMA SUSTITUIDA CON AMIDINA PARA SU USO EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS - Google Patents
FORMULACIONES LIPOSOMALES DE COMPUESTOS DE ß-LACTAMA SUSTITUIDA CON AMIDINA PARA SU USO EN EL TRATAMIENTO DE INFECCIONES BACTERIANASInfo
- Publication number
- UY37486A UY37486A UY0001037486A UY37486A UY37486A UY 37486 A UY37486 A UY 37486A UY 0001037486 A UY0001037486 A UY 0001037486A UY 37486 A UY37486 A UY 37486A UY 37486 A UY37486 A UY 37486A
- Authority
- UY
- Uruguay
- Prior art keywords
- lactama
- amidine
- treatment
- liposomal formulations
- bacterial infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención proporciona nuevas y eficaces formulaciones liposomales para la administración de beta-lactamas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16199658 | 2016-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY37486A true UY37486A (es) | 2018-06-29 |
Family
ID=57389241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001037486A UY37486A (es) | 2016-11-18 | 2017-11-17 | FORMULACIONES LIPOSOMALES DE COMPUESTOS DE ß-LACTAMA SUSTITUIDA CON AMIDINA PARA SU USO EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS |
Country Status (9)
Country | Link |
---|---|
US (1) | US20190328716A1 (es) |
EP (1) | EP3541382A1 (es) |
JP (1) | JP2019535724A (es) |
CN (1) | CN109982696A (es) |
AR (1) | AR110170A1 (es) |
CA (1) | CA3043976A1 (es) |
TW (1) | TW201828924A (es) |
UY (1) | UY37486A (es) |
WO (1) | WO2018091671A1 (es) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY34585A (es) * | 2012-01-24 | 2013-09-02 | Aicuris Gmbh & Co Kg | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso |
-
2017
- 2017-11-17 CA CA3043976A patent/CA3043976A1/en not_active Abandoned
- 2017-11-17 UY UY0001037486A patent/UY37486A/es not_active Application Discontinuation
- 2017-11-17 EP EP17797669.3A patent/EP3541382A1/en not_active Withdrawn
- 2017-11-17 TW TW106139996A patent/TW201828924A/zh unknown
- 2017-11-17 WO PCT/EP2017/079644 patent/WO2018091671A1/en unknown
- 2017-11-17 US US16/462,009 patent/US20190328716A1/en not_active Abandoned
- 2017-11-17 JP JP2019526264A patent/JP2019535724A/ja active Pending
- 2017-11-17 AR ARP170103204A patent/AR110170A1/es unknown
- 2017-11-17 CN CN201780071242.1A patent/CN109982696A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2019535724A (ja) | 2019-12-12 |
CN109982696A (zh) | 2019-07-05 |
TW201828924A (zh) | 2018-08-16 |
AR110170A1 (es) | 2019-03-06 |
WO2018091671A1 (en) | 2018-05-24 |
US20190328716A1 (en) | 2019-10-31 |
EP3541382A1 (en) | 2019-09-25 |
CA3043976A1 (en) | 2018-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2019012353A2 (es) | Formulaciones de anticuerpos anti-lag3 y coformulaciones de anticuerpos anti-lag3 y anticuerpos anti-pd-1 | |
DOP2019000180A (es) | INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS | |
CL2018000978A1 (es) | Macrociclos peptídicos contra acinetobacter baumannii | |
CL2018002012A1 (es) | Derivados de maitansinoide, conjugados de los mismos y métodos de uso. | |
CL2018001349A1 (es) | Composiciones que comprenden cepas bacterianas | |
CL2018001367A1 (es) | Composiciones que comprenden cepas bacterianas | |
CO2017001994A2 (es) | Compuestos activos hacia bromodominios | |
MD3209310T2 (ro) | Compoziții care conțin tulpini bacteriene | |
CL2016001231A1 (es) | Compuestos de inhibidor de autotaxina | |
CL2016002027A1 (es) | Ciclopropilamina como inhibidor de la lsd1 | |
CL2017002482A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
CL2015003686A1 (es) | Derivados de pirrolo[3,2-d]pirimidina para el tratamiento de infecciones víricas y otras enfermedades | |
CL2015002472A1 (es) | Como inhibidores de mutant idh-yl-oxazolidin-2-onas 3-pirimidin-4. | |
CL2018001171A1 (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso en el tratamiento del cáncer | |
CL2015003019A1 (es) | Derivados biaromáticos antibacterianos | |
EA201791454A1 (ru) | Лекарственные формы для трансдермального введения | |
CL2016002151A1 (es) | Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico | |
EP3280722B8 (en) | Antimicrobial peptides and their use for the treatment of topical infections | |
CL2015002180A1 (es) | Terapia de combinación para el tratamiento de neumonía nosocomial | |
CL2022000531A1 (es) | Composiciones y métodos para el tratamiento de infecciones virales. | |
CO2020006907A2 (es) | Péptidos antimicrobianos y métodos para usarlos | |
CL2017002451A1 (es) | Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
CL2017002803A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
CL2018002638A1 (es) | Ambrisentan para uso en el tratamiento de insuficiencia renal aguda | |
CL2016001977A1 (es) | Composición que comprende igm derivada de plasma y su uso para el tratamiento o prevención de afecciones inmunitarias. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20230705 |